Dr Reddys Laboratories (RDY) Revenue (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Revenue of $852.47 million for the quarter ended Jun 30, 2026, down 14.6% from $998.48 million a year earlier but up 3.7% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Revenue (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Dr Reddys Laboratories was $3.66 billion, down 6.7% year-over-year; for the year ended Mar 31, 2026, it was $3.58 billion, down 7.1% from the prior year.
- Annual Revenue shows a five-year compound annual growth rate of 6.7% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Revenue was $3.85 billion in the year ended Mar 31, 2025 (+15.0%), $3.35 billion in the year ended Mar 31, 2024 (+12.0%), $2.99 billion in the year ended Mar 31, 2023 (+5.9%) and $2.83 billion in the year ended Mar 31, 2022 (+8.9%).
- Quarterly Revenue has run from a low of $676.36 million in the quarter ended Jun 30, 2022 to a high of $1.01 billion in the quarter ended Sep 30, 2025 over five years.
- On a year-over-year basis, Revenue has declined in each of the last three quarters, with growth averaging 3.3% over the last eight quarters.
- The strongest year-over-year quarter for Revenue in the past five years was the quarter ended Jun 30, 2023, with growth of 22.4%; the weakest was the quarter ended Mar 31, 2026, with a decline of 16.3%.
- According to Business Quant data, Revenue for the three prior quarters was $822.21 million (quarter ended Mar 31, 2026), $979.97 million (quarter ended Dec 31, 2025) and $1.01 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Dr Reddys Laboratories | 10.73 Bn | 9.91 Bn | 396.53 Mn | 852.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 852.47 Mn |
| Mar 31, 2026 | 822.21 Mn |
| Dec 31, 2025 | 979.97 Mn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 998.48 Mn |
| Mar 31, 2025 | 982.28 Mn |
| Dec 31, 2024 | 989.97 Mn |
| Sep 30, 2024 | 957.09 Mn |
| Jun 30, 2024 | 919.78 Mn |
| Mar 31, 2024 | 852.90 Mn |
| Dec 31, 2023 | 866.49 Mn |
| Sep 30, 2023 | 832.30 Mn |
| Jun 30, 2023 | 828.00 Mn |
| Mar 31, 2023 | 811.00 Mn |
| Dec 31, 2022 | 767.00 Mn |
| Sep 30, 2022 | 824.00 Mn |
| Jun 30, 2022 | 676.36 Mn |
| Mar 31, 2022 | 723.04 Mn |
| Dec 31, 2021 | 717.00 Mn |
| Sep 30, 2021 | 701.00 Mn |
API Access
Dr Reddys Laboratories Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();